Nothing Special   »   [go: up one dir, main page]

IN2014MU00625A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00625A
IN2014MU00625A IN625MU2014A IN2014MU00625A IN 2014MU00625 A IN2014MU00625 A IN 2014MU00625A IN 625MU2014 A IN625MU2014 A IN 625MU2014A IN 2014MU00625 A IN2014MU00625 A IN 2014MU00625A
Authority
IN
India
Prior art keywords
relates
cytostatic
synthesis
preparation
present
Prior art date
Application number
Inventor
M V Ramana Dr M
S Lokhande Dr R
Ankita Laxman Mehta
Original Assignee
M V Ramana Dr M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M V Ramana Dr M filed Critical M V Ramana Dr M
Priority to IN625MU2014 priority Critical patent/IN2014MU00625A/en
Publication of IN2014MU00625A publication Critical patent/IN2014MU00625A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the synthesis of molecules showing cytostatic/cytotoxic potential against leukemia. Study relates to a process for the preparation of 1, 4-dihydropyridine derivatives and their anti leukemic activity.
IN625MU2014 2014-02-21 2014-02-21 IN2014MU00625A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN625MU2014 IN2014MU00625A (en) 2014-02-21 2014-02-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN625MU2014 IN2014MU00625A (en) 2014-02-21 2014-02-21

Publications (1)

Publication Number Publication Date
IN2014MU00625A true IN2014MU00625A (en) 2015-09-25

Family

ID=54394047

Family Applications (1)

Application Number Title Priority Date Filing Date
IN625MU2014 IN2014MU00625A (en) 2014-02-21 2014-02-21

Country Status (1)

Country Link
IN (1) IN2014MU00625A (en)

Similar Documents

Publication Publication Date Title
PH12017500507A1 (en) Cytotoxicity-inducing therapeutic agent
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
GEP20217211B (en) Substituted carbonucleoside derivatives useful as anticancer agents
SA519410795B1 (en) Synthesis of phosphate derivatives
CY1123920T1 (en) ANTI-INFLUENT POLYCYCLIC PYRIDONE DERIVATIVE AND ITS PRODRUG
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
EP4286387A3 (en) Methods of preparing cytotoxic benzodiazepine derivatives
JO3372B1 (en) 5-benzylisoquinoleine derivatives for the treatment of cardiovascular diseases
PH12017500853A1 (en) Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases
PL410329A1 (en) Ruthenium complexes, method for production and application
NZ740062A (en) Improved process for producing fucoxanthin and/or polysaccharides from microalgae
TN2016000490A1 (en) Naphthyridinedione derivatives.
NZ720106A (en) A process for the preparation of regadenoson
PH12016501997A1 (en) Cycloalkyl-linked diheterocycle derivatives
PH12016501613A1 (en) Pyrazines modulators of gpr6
PH12017501955A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease
MX2019002017A (en) Sofosbuvir derivatives for the treatment of hepatitis c.
MX2016015298A (en) Nampt inhibitors and methods.
MX2018015269A (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof.
PH12018500014A1 (en) Total synthesis of shishijimicin a and analogs thereof
IN2014MU00165A (en)
IN2014MU00625A (en)
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
IN2013DE03665A (en)
MX2017008655A (en) Jasmonate derivatives and compositions thereof.